Tirzepatide

Dual GIP/GLP-1 agonist peptide for advanced metabolic and weight-management research.

Tirzepatide is a synthetic peptide that simultaneously activates GIP and GLP-1 receptors. It stimulates insulin secretion, lowers blood glucose, reduces appetite, and supports significant body-weight reduction through enhanced satiety and reduced food intake. The dual mechanism offers potent glycemic control combined with fat-loss research applications. Supplied as 10 mg lyophilized powder for weekly subcutaneous injection protocols in research settings. Requires medical supervision in clinical contexts. For research use only.